GREEN CROSS HOLDINGS CORPORATION;MEDIGENEBIO CORPORATION
发明人:
JIN THONG-GYU,CHUNG YO KYUNG,PAIK SANG HOON,PARK YOO CHANG,SEO JINWOOK,CHOI YONG WOON,SON JONG MUN,KIM YONG-CHUL
申请号：
CO14010749
公开号：
CO6862105A2
申请日:
2014.01.21
申请国别(地区):
CO
年份:
2014
代理人:
摘要：
Disclosed is a composition comprising recombinant iduronate-2-sulfatase (IDS). The glycosylation pattern and formylglycine content of the IDS composition are different from those of Elaprase and have superior pharmaceutical efficacy and are safer than the conventional agent and thus can be effectively used for the therapy of Hunter syndrome.
